A. Guemriche

发表

Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis

E. Lanoy, P. Tiberghien, S. Grabar, 2022, Leukemia.

A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia

P. Rousselot, M. Delord, S. Rigaudeau, 2021, Haematologica.